NEW YORK — Forensic genomics company Othram said last week that it has raised $18 million in a Series B financing round led by Gigafund.
Othram combines DNA sequencing from degraded or low-input source material with advanced human identification applications. It has been working with academic researchers, forensic scientists, medical examiners, and law enforcement agencies on unsolved crimes. The Woodlands, Texas-based company said it will use the new funding to continue development of its genetic testing technology and expand its operations throughout North America.
"The family and friends of victims will not be around forever, and once they are gone then the opportunity to do right by them is lost," Othram CEO David Mittelman said in a statement. "We have technology that can bring answers and we need to make this technology available for all cases."
In 2019, Othram raised $4 million in Series A funding and was awarded a $10,000 research sequencing grant from Illumina Accelerator.